APOE and fatty liver disease: To investigate the molecular mechanisms responsible for the reduction in hepatic steatosis upon agmatine treatment of apoE−/− mice on Western HFD, we evaluated the mRNA and protein expression of several molecules associated with lipogenesis in the liver.